Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection

Journal: Nature Medicine

Published: 2020-08-03

DOI: 10.1038/s41591-020-1021-2

Affiliations: 11

Authors: 12

Go to article
Institutions Share
Department of Systems Biology, CU, United States of America (USA) 0.21
The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine (ICB), Cornell University, United States of America (USA) 0.15
Department of Biomedical Informatics (DBMI), CU, United States of America (USA) 0.13
Herbert Irving Comprehensive Cancer Center (HICCC), CU, United States of America (USA) 0.13
Department of Physiology and Biophysics, Cornell University, United States of America (USA) 0.10
Department of Genetics and Genomic Sciences, ISMMS, United States of America (USA) 0.08
Hasso Plattner Institute for Digital Health at Mount Sinai (HPIMS), United States of America (USA) 0.08
Department of Physiology and Cellular Biophysics, CU, United States of America (USA) 0.04
Vagelos College of Physicians and Surgeons (P&S), CU, United States of America (USA) 0.04
WorldQuant Initiative for Quantitative Prediction, United States of America (USA) 0.02
Feil Family Brain and Mind Research Institute (BMRI), Cornell University, United States of America (USA) 0.02

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER